Your session is about to expire
← Back to Search
Auditory-Cognitive Training for Hearing Loss (ARCog Trial)
ARCog Trial Summary
This trial will investigate whether an auditory brain training program can improve cochlear implant outcomes in older post-lingually deafened CI users. The study will evaluate the potential benefit of training on speech recognition performance, psychosocial and cognitive function.
ARCog Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowARCog Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ARCog Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are deaf in one ear.My cochlear implant was activated between 3 months and 3 years ago.I am 60 years old or older.Your ability to understand speech (using the AZBio test) falls between 10% and 85%.I am not fluent in English.I passed a test that checks for thinking problems.
- Group 1: Treatment: Auditory-Cognitive Training
- Group 2: Control: Non-auditory Cognitive Training
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for participants in this investigation?
"Yes, the clinical trial is open to recruitment. According to records on clinicaltrials.gov, this project was initially shared in May of 2022 and has been updated as recently as August 2nd of the same year."
How many participants are actively engaging in this medical experiment?
"Yes, indeed. Data from clinicaltrials.gov confirms that recruitment for the trial is ongoing; it was initially posted on May 1st 2022 and most recently edited in August 2nd 2022. The study requires a total of 30 participants to be enrolled at one medical centre."
Share this study with friends
Copy Link
Messenger